Regenerative MedicineResearch PaperPaywall

Long-Term Culture Ages Stem Cells Through a DNA-PKcs and DNMT3A Pathway

In mouse pluripotent stem cells, prolonged culture triggers aging-like decline via Lamin A loss, DNA-PKcs inactivation and lower DNMT3A. This matters for iPSC therapies.

Thursday, November 19, 2026 0 views
Published in Adv Sci (Weinh)
a scientist pipetting stem cell culture medium into a multi-well plate inside a biosafety cabinet

Summary

Induced pluripotent stem cells (iPSCs) are often assumed to be ageless, able to renew indefinitely. This cell-culture study in mouse pluripotent stem cells suggests otherwise. After long-term passaging, the cells showed aging-like decline: weaker repair of DNA breaks by non-homologous end joining, loss of cellular identity, and reduced ability to differentiate. The authors trace a chain of events. Falling Lamin A levels inactivate the DNA repair enzyme DNA-PKcs. That in turn lowers DNMT3A, an enzyme that sets DNA methylation, through the transcription factors SP1/3, producing gene-expression patterns resembling aging and weakening pluripotency. The work links DNA damage repair to epigenetic control in one pathway and points to targets that might preserve cell quality. It is a mouse cell study, summarized here from the abstract only. It does not show effects in human cells, in living animals or on lifespan, and it does not test any therapy in people.

Detailed Summary

Why this matters: Regenerative medicine hopes to use induced pluripotent stem cells (iPSCs) to treat age-related disease. iPSCs are widely believed to be ageless, renewing indefinitely without losing quality. If they instead deteriorate during the long culture needed to expand them, the cells used for therapy could be compromised.

What was studied: The researchers examined mouse pluripotent stem cells maintained over prolonged passaging and asked whether they acquire features of aging at the molecular and functional level. They then worked out the mechanism behind any decline, focusing on DNA repair and epigenetic regulation.

Key results: Long-term cultured cells showed aging-like deterioration. Repair of DNA breaks through non-homologous end joining (NHEJ) was impaired, cellular identity was lost, and differentiation potential diminished. Mechanistically, decreasing Lamin A triggered inactivation of DNA-PKcs, a core NHEJ kinase. This inactivation suppressed expression of DNMT3A, a DNA methyltransferase, via the transcription factors SP1/3, and induced transcriptomic signatures characteristic of aging. The end result was impaired pluripotency. In plain terms, a nuclear scaffold protein loss weakens DNA repair, which then alters the epigenetic machinery, and the cells drift toward an older state.

Implications: The findings frame iPSC aging as a product of DNA damage and epigenetics talking to each other, and they argue for monitoring genomic stability during culture. The authors also say they identified feasible targets for improving cell quality in clinical applications. The pathway also connects to wider aging biology, where DNA repair decline and epigenetic drift are recognized hallmarks.

Caveats: This summary rests on the abstract only. The model is mouse pluripotent stem cells in culture, so nothing here shows the same process in human iPSCs, in living animals, or in patients. Mechanism and cell function were reported; lifespan was not assessed. Details on sample sizes, rescue experiments and statistics were not available, and no therapeutic intervention has been tested in people.

Key Findings

  • Mouse pluripotent stem cells kept in long-term culture acquired aging-like molecular and functional deterioration (cell model, mechanism and function).
  • Long-term culture impaired non-homologous end joining DNA repair, caused loss of cellular identity, and reduced differentiation potential.
  • Falling Lamin A levels triggered DNA-PKcs inactivation, which the authors identify as the cause of impaired NHEJ during prolonged culture.
  • DNA-PKcs inactivation suppressed DNMT3A via SP1/3, producing aging-like transcriptomic signatures and impaired pluripotency.
  • No lifespan, in vivo or human data are reported in the abstract; the authors suggest monitoring genomic stability in iPSC production.

Methodology

Preclinical cell-culture study in mouse pluripotent stem cells, comparing long-term passaged cells with earlier ones and dissecting a Lamin A, DNA-PKcs, SP1/3 and DNMT3A pathway. Assessed DNA repair, cell identity, differentiation capacity and transcriptomic aging signatures. Specific methods and sample sizes were not available in the abstract.

Study Limitations

This summary is based on the abstract only, so design details, controls and statistics could not be assessed. The work is in mouse cells in culture, with no demonstration in human iPSCs, in vivo, or on lifespan or clinical outcomes. The proposed targets for improving cell quality are not yet shown to work in therapeutic settings.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: